(Press-News.org) April 21, 2013, New York, NY and San Diego Calif. – Ludwig researchers Arshad Desai and Christopher Campbell, a post-doctoral fellow in his laboratory, were conducting an experiment to parse the molecular details of cell division about three years ago, when they engineered a mutant yeast cell as a control that, in theory, had no chance of surviving. Apparently unaware of this, the mutant thrived.
Intrigued, Campbell and Desai began exploring how it had defied its predicted fate. As detailed in the current issue of Nature, what they discovered has overturned the prevailing model of how dividing cells ensure that each of their daughter cells emerge with equal numbers of chromosomes, which together package the genome. "Getting the right number of chromosomes into each cell is absolutely essential to sustaining life," explains Desai, PhD, a Ludwig member at the University of California, San Diego, "but it is also something that goes terribly wrong in cancer. The kinds of mistakes that occur when this process isn't functioning properly are seen in about 90% of cancers, and very frequently in advanced and drug-resistant tumors."
Campbell and Desai's study focused in particular on four interacting proteins known as the chromosomal passenger complex (CPC) that monitor the appropriate parceling out of chromosomes. When cells initiate division, each chromosome is made of two connected, identical sister chromatids—roughly resembling a pair of baguettes joined in the middle. As the process of cell division advances, long protein ropes known as microtubules that extend from opposite ends of the cell hook up to the chromosomes to yank each of the sister chromatids in opposite directions. The microtubules attach to the chromatids via an intricate disc-like structure called the kinetochore. When the protein ropes attach correctly to the sister chromatids, pulling at each from opposing sides, they generate tension on the chromosome. One of the four proteins of the CPC, Aurora B kinase, is an enzyme that monitors that tension. Aurora B is expressed at high levels in many cancers and has long been a target for the development of cancer therapies.
Aurora B is essentially a molecular detector. "If the chromosomes are not under tension," says Desai, "Aurora B forces the rope to release the kinetochore and try attaching over and over again, until they achieve that correct, tense attachment."
The question is how? Aurora B is ordinarily found between the two kinetochores in a region of the chromosome that links the sister chromatids, known as the centromere. The prevailing model held that the microtubule ropes would pull themselves, and the kinetochores, away from Aurora B's reach, so that it cannot force the microtubule ropes to detach from their captive chromosomes. In other words, the location of Aurora B between the two kinetochore discs was thought to be central to its role as a monitor of the requisite tension. "This matter was thought settled," says Desai.
Yet, as Campbell and Desai show through their experiments, yeast cells engineered to carry a mutant CPC that can't be targeted to the centromere survive quite vigorously. They demonstrate that in such cells Aurora B instead congregates on the microtubule ropes. There, it somehow still ensures that the required tension is achieved on chromosomes before they are parceled out to daughter cells.
How precisely it does this remains unclear. Campbell and Desai provide evidence that the clustering of Aurora B on microtubules might be sufficient to activate its function. At the same time, they hypothesize, appropriate tension on the chromosome may induce structural changes in Aurora B's targets that make them resistant to its enzymatic activity. Campbell and Desai are now conducting experiments to test these ideas.
INFORMATION:
This work was supported by the Ludwig Institute for Cancer Research, the National Institutes of Health (GM074215) and the Damon Runyon Cancer Research Foundation Fellowship (DRG 2007-09).
About The Ludwig Institute for Cancer Research
The Ludwig Institute for Cancer Research is an international non-profit organization committed to improving the understanding and control of cancer through integrated laboratory and clinical discovery. Leveraging its worldwide network of investigators and the ability to sponsor and conduct its own clinical trials, Ludwig is actively engaged in translating its discoveries into applications for patient benefit. Since its establishment in 1971, the Ludwig Institute has expended more than $1.5 billion on cancer research.
For further information please contact Rachel Steinhardt, rsteinhardt@licr.org or +1-212-450-1582.
END
A new analysis has found that the loss or amplification of particular DNA regions contributes to the development of prostate cancer, and that patients with two of these DNA changes have a high likelihood of dying from the disease. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study provides valuable information on the genetics of prostate cancer and offers insights into which patients should be treated aggressively.
Cells can become cancerous when they lose or amplify pieces of DNA containing important genes. Using a method ...
It is widely accepted that medical insurance helps older adults with chronic health problems to receive better care. But what about young adults between the ages of 18 and 25, a demographic that also tends to have the lowest levels of health insurance coverage?
In what may be the first study to measure health care utilization patterns among young adults with chronic health problems—in this case asthma—a team of researchers at Harvard Medical School found that losing health insurance was a significant predictor of deteriorating patterns of health management. Other social ...
New research published as an abstract in The FASEB Journal and presented at Experimental Biology 2013 (EB 2013) on Monday, April 22 ties mushrooms to positive health outcomes in the area of weight management. A one-year, randomized clinical trial conducted by researchers at the Weight Management Center at Johns Hopkins Bloomberg School of Public Health and funded by the Mushroom Council found that substituting white button mushrooms for red meat can be a useful strategy for enhancing and maintaining weight loss.1
Participants included obese adults (73 adults; 88% women; ...
Anyone who has spent time in the tropics knows that the diversity of species found there is astounding and the abundance and diversity of ants, in particular, is unparalleled. Scientists have grappled for centuries to understand why the tropics are home to more species of all kinds than the cooler temperate latitudes on both sides of the equator. Several hypotheses have been proposed to explain the higher species numbers in the tropics, but these hypotheses have never been tested for the ants, which are one of the most ecologically and numerically dominant groups of animals ...
Researchers from ETH Zurich, the Paul Scherrer Institute (PSI) and the Politec-nico di Milano have jointly developed a manufacturing technique to render the semiconductor germanium laser-compatible through high tensile strain. In their article recently published in "Nature Photonics", they reveal how they can gen-erate the necessary tensile strain efficiently. The scientists demonstrate how to use their method to effectively alter the optical properties of germanium, which is naturally unsuitable for lasing: "With a strain of three per cent, the material emits around twenty-five ...
But an accompanying series of editorials points out some important limitations of the two studies—which can't completely overcome previous concerns about the safety of using nitrous oxide (N2O) as a surgical anesthetic.
Is Nitrous Oxide Safe for Surgical Anesthesia?
Nitrous oxide is the world's oldest general anesthetic, but there's a long history of debate regarding its appropriate role in modern surgical anesthesia. Although nitrous oxide provides effective sedation and pain control, it has known disadvantages and side effects. A previous study, called "ENIGMA-I," ...
Josh Hill, an experienced business-to-business marketer announced availability of the Marketing Rockstar's Guide to Marketo, an independent project aimed at marketers who are new to the marketing automation tool Marketo.
Josh started the project to keep track of the many ways Marketo can be used as well as best practice setup techniques. Having gone through previous Marketo implementations with Salesforce.com, Josh believed there was a gap between Marketo documentation and marketers' technical skills.
"I work at the nexus of technology, marketing, and sales to ...
Charles & Chubs Pet Furnishings aims to raise funding to manufacture their line of pet products through crowd-funding website, Kickstarter. The primary goal at this time is to get their line of pet beds manufactured out of high-grade plastic with a design that allows the beds to fold nearly flat for storage.
Charles & Chubs Pet Furnishings is a startup company with a vision of creating unique pet furniture that not only allow your pet to sleep in style but also make for a decorative piece in your home.
"I wanted to create a pet bed that was more than ...
Andre and Marina Soumiatin have officially put the relationship experts on notice: They have created an interactive, "Wiki-style" project in which people's feedback, commentary and questions directly affect the outcome of a book entitled "Timeless Love Pyramid- 5 Essential Steps to Keep Your Passion". This book teaches how to keep passion in a marriage for a life time. People are sharing their love stories and expressing their feelings on what they want to read.
People are raving about their experiences:
"I just read your first chapter on ...
Several new Stark law initiatives have recently gone into effect, yet the application of those provisions is unclear to many healthcare professionals and patients.
"A common misunderstanding is that Stark law applies across the board to all patients, but it does not," says Dr. Carol Mahon, chief compliance officer of Minimally Invasive SpineCARE and CEO of Medical Business Institute. "Stark law only applies to government-funded entities - like Medicare and Medicaid.
"There are safe harbors or exceptions to the law that could affect a lot of people ...
